AADAC Polyclonal Antibody | G-AB-00680
- 3 to 5 Working Days
AADAC Polyclonal Antibody | G-AB-00680 | Gentaur Antibodies
Overview: Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens. Arylacetamide deacetylation is an important enzyme activity in the metabolic activation of arylamine substrates to ultimate carcinogens. Displays major serine hydrolase activity in liver microsomes. Hydrolyzes also flutamide, which is an antiandrogen drug used for the treatment of prostate cancer that occasionally causes severe hepatotoxicity. Displays cellular triglyceride lipase activity in liver. Increases intracellular fatty acids derived from hydrolysis of newly formed triglyceride stores.
Category Type: Polyclonal Antibody
Research Areas: Metabolism, Signal Transduction
Synonyms: AAAD, Aada, Aadac, Arylacetamide deacetylase (esterase) , Arylacetamide deacetylase, CES5A1, DAC
Accession #: BC032309
Immunogen: Recombinant protein of human AADAC
Santa Cruz: sc-99249
Calculated MW: 46 kDa
Concentration: 0.2 mg/mL
Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Purification method: Affinity purification
Application: WB, IHC, ELISA
Dilution: WB 1:500-1:2000, IHC 1:50-1:100
Storage: Store at -20°C. Avoid freeze / thaw cycles.
1 Review Hide Reviews Show Reviews
The shipping time of the parcel was extraordinary. I got the parcel in just 5 days.